92 related articles for article (PubMed ID: 1449475)
21. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
22. A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H
Zhou Y; Lin M; Wang J; Chen F; Li F; Chen W; Han L; Wang C; Chen J; Shao JW; Jia L
Free Radic Biol Med; 2018 Dec; 129():107-115. PubMed ID: 30227269
[TBL] [Abstract][Full Text] [Related]
23. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
Anning PB; Grocott-Mason RM; Lewis MJ
Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
[TBL] [Abstract][Full Text] [Related]
24. Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?
Ribuot C; Cardinal R; Gouin L; Moreau P; Godin D; Vermeulen M; de Champlain J; Rochette L; Nadeau R
Cardiovasc Res; 1994 Feb; 28(2):221-7. PubMed ID: 8143304
[TBL] [Abstract][Full Text] [Related]
25. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
[TBL] [Abstract][Full Text] [Related]
26. The reaction of S-nitroso-N-acetyl-D,L-penicillamine (SNAP) with the angiotensin converting enzyme inhibitor, captopril--mechanism of transnitrosation.
Aquart DV; Dasgupta TP
Org Biomol Chem; 2005 May; 3(9):1640-6. PubMed ID: 15858644
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
[TBL] [Abstract][Full Text] [Related]
28. [Effect of captopril on angiotensin-converting enzyme activity and animal behavior in the "open field" test].
Vernigora AN; Gengin MT; Nikishin NN; Shchetinina NV
Vopr Med Khim; 1996; 42(1):34-8. PubMed ID: 8999656
[TBL] [Abstract][Full Text] [Related]
29. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.
Forhead AJ; Whybrew K; Hughes P; Broughton Pipkin F; Sutherland M; Fowden AL
Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426
[TBL] [Abstract][Full Text] [Related]
30. The effects of S-nitrosocaptopril on canine coronary circulation.
Nakae I; Takahashi M; Kinoshita T; Matsumoto T; Kinoshita M
J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
[TBL] [Abstract][Full Text] [Related]
31. [Determination of the inhibitory activity of angiotensin-converting enzyme inhibitor captopril by high performance capillary electrophoresis].
Xin ZH; Ma HL; Wu SY; Dai CH
Yao Xue Xue Bao; 2003 Nov; 38(11):843-5. PubMed ID: 14991998
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
Yamamoto D; Takai S; Miyazaki M
Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies of angiotensin converting enzyme inhibitors with and without the SH-radical.
Nakagawa M; Kobayashi K; Sawada S; Toyoda T; Shirai K; Katoh K; Yamamoto K; Tsuji H; Sasaki S; Takeda K
Am J Hypertens; 1991 Jan; 4(1 Pt 2):54S-55S. PubMed ID: 1848988
[TBL] [Abstract][Full Text] [Related]
34. Modulation of G-protein expression by the angiotensin converting enzyme inhibitor captopril in hearts from spontaneously hypertensive rats. Relationship with adenylyl cyclase.
Pandey SK; Anand-Srivastava MB
Am J Hypertens; 1996 Aug; 9(8):833-7. PubMed ID: 8862232
[TBL] [Abstract][Full Text] [Related]
35. Free radical scavenging properties of alacepril metabolites and lisinopril.
Noda Y; Mori A; Packer L
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
[TBL] [Abstract][Full Text] [Related]
36. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360
[TBL] [Abstract][Full Text] [Related]
37. Zofenoprilat-glutathione mixed disulfide as a specific S-thiolating agent of bovine lens aldose reductase.
Dal Monte M; Del Corso A; Moschini R; Cappiello M; Amodeo P; Mura U
Antioxid Redox Signal; 2005; 7(7-8):841-8. PubMed ID: 15998238
[TBL] [Abstract][Full Text] [Related]
38. Studies on the nöotropic potential of some angiotensin converting enzyme inhibitors in the mouse.
Manning-Sayi J; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):953-62. PubMed ID: 2682788
[TBL] [Abstract][Full Text] [Related]
39. Renal-selective delivery and angiotensin-converting enzyme inhibition by subcutaneously administered captopril-lysozyme.
Prakash J; van Loenen-Weemaes AM; Haas M; Proost JH; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
Drug Metab Dispos; 2005 May; 33(5):683-8. PubMed ID: 15673598
[TBL] [Abstract][Full Text] [Related]
40. Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Kotikoski H; Kankuri E; Vapaatalo H
Med Sci Monit; 2003 Jan; 9(1):BR1-7. PubMed ID: 12552230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
